Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease

Lhassane Ismaili, Bernard Refouvelet, Mohamed Benchekroun, Simone Brogi, Margherita Brindisi, Sandra Gemma, Giuseppe Campiani, Slavica Filipic, Danica Agbaba, Gerard Esteban, Mercedes Unzeta, Katarina Nikolic, Stefania Butini, José Marco-Contelles

Research output: Contribution to journalReview articleResearchpeer-review

85 Citations (Scopus)

Abstract

© 2016 Elsevier Ltd Alzheimer's disease is a multifactorial and fatal neurodegenerative disorder characterized by decline of cholinergic function, deregulation of other neurotransmitter systems, β-amyloid fibril deposition, and β-amyloid oligomers formation. Based on the involvement of a relevant number of biological systems in Alzheimer's disease progression, multitarget compounds may enable therapeutic efficacy. Accordingly, compounds possessing, besides anticholinergic activity and β-amyloid aggregation inhibition properties, metal chelating and/or nitric oxide releasing properties with additional antioxidant capacity were developed. Other targets relevant to Alzheimer's disease have also been considered in the last years for producing multitarget compounds such as β-secretase, monoamino oxidases, serotonin receptors and sigma 1 receptors. The purpose of this review will be to highlight recent reports on the development of multitarget compounds for Alzheimer's disease published within the last years focusing on multifunctional ligands characterized by tacrine-like and donepezil-like structures.
Original languageEnglish
Pages (from-to)4-34
JournalProgress in Neurobiology
Volume151
DOIs
Publication statusPublished - 1 Apr 2017

Keywords

  • Acetylcholinesterase
  • Alzheimer's disease
  • Beta secretase
  • Butyrylcholinesterase
  • Cholinesterases
  • Histamine receptor
  • Monoamine oxidases
  • Multi-target-directed ligand
  • Nitric oxide
  • Reactive oxygen species
  • Serotonin receptors
  • β-Amyloid

Fingerprint Dive into the research topics of 'Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease'. Together they form a unique fingerprint.

  • Cite this

    Ismaili, L., Refouvelet, B., Benchekroun, M., Brogi, S., Brindisi, M., Gemma, S., Campiani, G., Filipic, S., Agbaba, D., Esteban, G., Unzeta, M., Nikolic, K., Butini, S., & Marco-Contelles, J. (2017). Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease. Progress in Neurobiology, 151, 4-34. https://doi.org/10.1016/j.pneurobio.2015.12.003